Drug distributors, Johnson & Johnson reach $26 billion deal to resolve opioid lawsuits

“We recognize the opioid crisis is a tremendously complex public health issue, and we have deep sympathy for everyone affected,” Michael Ullmann, the company’s executive vice president, general counsel, wrote in a statement. “This settlement will directly support state and local efforts to make meaningful progress in addressing the opioid crisis in the United States.”

View original article here Source

Related Posts